CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ReShape Lifesciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ReShape Lifesciences Inc
1001 CALLE AMANECER
Phone: (949) 429-6680p:949 429-6680 SAN CLEMENTE, CA  92673  United States Ticker: RSLSRSLS
Business Summary
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer and Director AndrewRasdal
Executive Chairman of the Board Dan W.Gladney 70 7/1/2022 11/1/2015
Chief Financial Officer WilliamPlovanic
17 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ReShape Medical, Inc. 100 Calle Iglesia San Clemente CA United States
ReShape Weightloss Inc 1001 Calle Amanecer SAN CLEMENTE CA United States

Business Names
Business Name
Obalon Center for Weight Loss, Inc.
OBLN
ReShape Costa Rica Sociedad de Responsabilidad Limited
7 additional Business Names available in full report.

General Information
Number of Employees: 31 (As of 12/31/2023)
Outstanding Shares: 23,457,090 (As of 3/26/2024)
Shareholders: 34
Stock Exchange: NASD
Federal Tax Id: 261828101
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024